person · Reporting owner
DE SCHUTTER RICHARD U
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | March 29, 2024 | April 02, 2024 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | March 31, 2023 | April 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date March 29, 2024 · Filed April 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 32,952 |
Reported balance
After 2024-03-29 transaction · row 1
1 source rowRow 1 · 2024-03-29 · Grant · Acquired 1,553 · Balance 32,952 F1: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.
Bausch Health Companies Inc.
Report date March 31, 2023 · Filed April 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 373,407 |
Reported balance
After 2023-03-31 transaction · row 1
1 source rowRow 1 · 2023-03-31 · Grant · Acquired 3,642 · Balance 373,407 F1: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. |
| Common Shares, No Par ValueSEC Table I · non-derivative | IndirectBy spouse | 13,800 |
Reported balance
Holding disclosure · report date 2023-03-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 13,800 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2024 Filed Apr 2, 2024 16:04 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,553 | $17.30 | $26,866.90 |
DisclosureSEC source: 0001127602-24-011811 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,952 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 16:41 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,575 | $17.06 | $26,869.50 |
DisclosureSEC source: 0001127602-24-000483 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,399 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 17:15 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,585 | $16.95 | $26,865.75 |
DisclosureSEC source: 0001127602-23-025311 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,824 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 16:05 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,339 | $20.07 | $26,873.73 |
DisclosureSEC source: 0001127602-23-019996 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,239 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| May 04, 2023 Filed May 5, 2023 16:19 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014685 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,900 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:02 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,642 | $8.10 | $29,500.20 |
DisclosureSEC source: 0001127602-23-012409 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,407 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:16 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,543 | $17.41 | $26,863.63 |
DisclosureSEC source: 0001127602-23-012184 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,043 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,186 | $6.28 | $32,568.08 |
DisclosureSEC source: 0001127602-23-000171 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,765 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:40 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,989 | $6.89 | $34,374.21 |
DisclosureSEC source: 0001127602-22-023257 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,579 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:59 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,111 | $8.36 | $34,367.96 |
DisclosureSEC source: 0001127602-22-018798 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,590 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:40 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018203 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,479 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 10, 2022 Filed May 12, 2022 19:37 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017852 · doc4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:57 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,504 | $22.85 | $34,366.40 |
DisclosureSEC source: 0001127602-22-011286 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,092 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:17 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,245 | $27.61 | $34,374.45 |
DisclosureSEC source: 0001127602-22-000105 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,588 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:41 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,234 | $27.85 | $34,366.90 |
DisclosureSEC source: 0001127602-21-026451 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,343 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 20:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Shares, No Par Value | 10,000 | $25.01 | $250,123.00 |
DisclosureSEC source: 0001127602-21-023267 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,109 F1 · price: The price in Column 4 reflects the average weighted purchase price for the transactions aggregated on this Form 4. The purchase price per share reported on this Form 4 range from $25.00 to $25.03. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,172 | $29.32 | $34,363.04 |
DisclosureSEC source: 0001127602-21-021208 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,109 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014906 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,937 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,070 | $31.74 | $33,961.80 |
DisclosureSEC source: 0001127602-21-012714 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,292 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,622 | $20.80 | $33,737.60 |
DisclosureSEC source: 0001127602-21-000247 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,222 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:01 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 2,171 | $15.54 | $33,737.34 |
DisclosureSEC source: 0001127602-20-026306 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,600 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,750 | $18.29 | $32,007.50 |
DisclosureSEC source: 0001127602-20-020902 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,429 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 01, 2020 Filed May 1, 2020 20:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 11,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015023 · form4.xml · nonDerivative · entry 2 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,679 F2 · shares: Represents the award of RSUs granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in Common Shares. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 624 | $18.11 | $11,300.64 |
DisclosureSEC source: 0001127602-20-015023 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,642 F1 · shares: This number represents common shares, no par value, of the Issuer ("Common Shares") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs"). Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 2,016 | $15.50 | $31,248.00 |
DisclosureSEC source: 0001127602-20-012702 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,266 Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 00:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, No Par Value | 3,800 | $18.26 | $69,377.36 |
DisclosureSEC source: 0001127602-20-010313 · form4.xml · nonDerivative · entry 2 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 13,800 Read SEC document |
| March 03, 2020 Filed Mar 12, 2020 00:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, No Par Value | 5,000 | $23.08 | $115,415.00 |
DisclosureSEC source: 0001127602-20-010313 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,250 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,044 | $29.92 | $31,236.48 |
DisclosureSEC source: 0001127602-20-000165 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,250 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,430 | $21.85 | $31,245.50 |
DisclosureSEC source: 0001127602-19-029777 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,206 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,239 | $25.22 | $31,247.58 |
DisclosureSEC source: 0001127602-19-023535 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,776 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:13 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017259 · form4.xml · nonDerivative · entry 2 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,537 F2 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:13 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 3,996 | $23.63 | $94,425.48 |
DisclosureSEC source: 0001127602-19-017259 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,904 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 20:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,265 | $24.70 | $31,245.50 |
DisclosureSEC source: 0001127602-19-014648 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,900 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,691 | $18.47 | $31,232.77 |
DisclosureSEC source: 0001127602-19-000691 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,635 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,217 | $25.67 | $31,240.39 |
DisclosureSEC source: 0001127602-18-029059 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,944 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 19:00 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, No Par Value | 125,000 | $23.96 | $2,995,000.00 |
DisclosureSEC source: 0001127602-18-027737 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,727 F1 · price: The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $23.81 to $24.07 per share. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:49 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,344 | $23.24 | $31,234.56 |
DisclosureSEC source: 0001127602-18-022665 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,727 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:43 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, No Par Value | 15,000 | $21.83 | $327,450.00 |
DisclosureSEC source: 0001127602-18-017910 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,383 F1 · price: The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $21.56 to $22.05 per share. Read SEC document |
| May 15, 2018 Filed Jul 3, 2018 20:49 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, No Par Value | 10,000 | $21.80 | $218,000.00 |
DisclosureSEC source: 0001127602-18-022665 · form4.xml · nonDerivative · entry 2 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 10,000 Read SEC document |
| May 03, 2018 Filed May 4, 2018 21:53 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 14,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016405 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,787 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant. Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:33 UTC Amendment | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 13,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016649 · form4a.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,383 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:42 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | Tax withholdingCommon Stock, No Par Value | 3,522 | $18.07 | $63,642.54 |
DisclosureSEC source: 0001127602-18-016230 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,502 Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 20:53 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,962 | $15.92 | $31,235.04 |
DisclosureSEC source: 0001127602-18-013755 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,024 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| March 08, 2018 Filed Mar 13, 2018 00:59 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, No Par Value | 10,000 | $15.34 | $153,400.00 |
DisclosureSEC source: 0001127602-18-011288 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,062 F1 · price: The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $15.01 to $16.00 per share. F2 · price: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range reported above. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 15:21 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,503 | $20.78 | $31,232.34 |
DisclosureSEC source: 0001127602-18-000343 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,062 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 23:26 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, No Par Value | 10,000 | $14.33 | $143,300.00 |
DisclosureSEC source: 0001127602-17-033073 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,559 Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 21:41 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 2,180 | $14.33 | $31,239.40 |
DisclosureSEC source: 0001127602-17-029031 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,559 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:39 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, No Par Value | 4,900 | $14.35 | $70,315.00 |
DisclosureSEC source: 0001127602-17-026211 · form4.xml · nonDerivative · entry 2 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,379 Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:39 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, No Par Value | 5,100 | $14.31 | $72,981.00 |
DisclosureSEC source: 0001127602-17-026211 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,479 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:36 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,807 | $17.30 | $31,261.10 |
DisclosureSEC source: 0001127602-17-023000 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,379 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.